Clinical Trial Update: Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating three doses of S47445 versus placebo in mild-to-moderate Alzheimer's disease with depressive symptoms, reporting efficacy and safety re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• S47445

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED